Pharmacovigilance in the age of COVID-19

COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?

Perspective / 29 April 2020

Director’s message, Issue 82

After months of wintry grey skies, the sun came. And the coronavirus. Suddenly, we find ourselves in the middle of a crisis.

Perspective / 22 April 2020

10 critical steps to improve patient safety worldwide

New 10-point plan urged to improve detection, analysis, and reporting of harms from medicines and devices to improve patient safety.

Perspective / 10 March 2020

Community is the future of pharmacovigilance

A pharmacoepidemiologist reflects on two decades of international pharmacovigilance training and sees the future in a strengthening global community of practitioners.

Perspective / 22 October 2019

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more